Cytodyn Inc (CYDY)

[Saltz]

Lol Energy. Need to break this out over a buck and make good on timelines that de-risk Pro-140. Hanging under a buck is like an endless hangover.

Execution is the juice needed here. Adjunct enrollment completed and Mono Trial1st patient injected are at the top of the list. Should likely get Mono news before 2017. Bottom line is Pro-140 will not be taken seriously by BP or institutions until approval appears to be a given. There is No question as to the efficacy and safety of Pro-140. Regardless the FDA is the gatekeeper that decides how many hoops to jump through and they seem to be supportive. 2017 will answer those questions. Not that long to wait after being in for nearly four years.